Skip to main content
Premium Trial:

Request an Annual Quote

NIH Offers $200K-$400K Proteomics and Glycomics Grants for SBCs

NEW YORK, Jan. 30 (GenomeWeb News) - The National Institutes of Health has issued a request for applications for projects focused on the development of new proteomics and glycomics research tools. The grant opportunity is open to US small businesses and individuals.

The FOA, said the NIH, has special interest in projects focused on "the unique needs of glycomics and clinical proteomics" and is "open to unconventional or alternative approaches."

The SBIR/STTR grants outlay up to $200,000 per year for up to for two years during phase I and up to $400,000 per year for up to four years during phase II.

Applications for funding open on March 1. The RFA expires on April 2. Additional details can be found here.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.